- Represented AGA Medical Corporation (“AGA”) in its sale to Welsh, Carson, Anderson & Stowe (“WCAS”).
- AGA Medical Corporation is a leading innovator of medical devices for the treatment of congenital heart defects. AGA develops, manufactures, and markets a complete line of cardiovascular implants for both the adult and pediatric markets. AGA, founded in 1995, realized tremendous success due to a unique product design and superior product performance that replaced open-heart surgery for tens of thousands of infants and adults.
- Key drivers of interest include growth in new markets and products, high margins, and high market share.